Gluten sensitivity and relationship to psychiatric symptoms in people with schizophrenia

Schizophrenia Research

Volumn 159, Issue 2-3, 2014, Pages 539-542

  Jackson, Jessica ^a   Eaton, William ^b   Cascella, Nicola ^c   Fasano, Alessio ^d   Santora, Debby ^e   Sullivan, Kelli ^e   Feldman, Stephanie ^e   Raley, Heather ^f   McMahon, Robert P ^e   Carpenter, William T ^e   Demyanovich, Haley ^e   Kelly, Deanna L ^e  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c SHEPPARD PRATT HEALTH SYSTEM   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^f NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

Celiac disease; Gliadin; Gluten; Gluten sensitivity; Schizophrenia

Indexed keywords

GLIADIN ANTIBODY; GLUTEN; GLIADIN;

ADULT; AGITATION; ANXIETY; ARTICLE; BRIEF PSYCHIATRIC RATING SCALE; CALGARY DEPRESSION SCALE; CELIAC DISEASE; CONSTIPATION; CONTROLLED STUDY; DELUSION; DEPRESSION; DISORIENTATION; FEMALE; GLUTEN FREE DIET; GLUTEN SENSITIVITY; HALLUCINATION; HOSTILITY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; PARANOID PSYCHOSIS; POSITIVE SYNDROME; PREVALENCE; RATING SCALE; REPEATABLE BATTERY OF THE ASSESSMENT OF NEUROPSYCHOLOGICAL STATUS; RESIDUAL SCHIZOPHRENIA; RESTLESSNESS; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SCORING SYSTEM; SYMPTOMATOLOGY; COMORBIDITY; HYPERSENSITIVITY; IMMUNOLOGY; PATHOPHYSIOLOGY; PSYCHOTIC DISORDERS;

ADULT; COMORBIDITY; FEMALE; GLIADIN; HUMANS; HYPERSENSITIVITY; MALE; PSYCHOTIC DISORDERS; SCHIZOPHRENIA;

EID: 84920874223     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2014.09.023     Document Type: Article

References (33)

1. Addington D., Addington J., Maticka-Tyndale E. Assessing depression in schizophrenia: the Calgary Depression Scale. Br. J. Psychiatry Suppl. 1993, (22):39-44.
2. Addolorato G., Stefanini G.F., Capristo E., Caputo F., Gasbarrini A., Gasbarrini G. Anxiety and depression in adult untreated celiac subjects and in patients affected by inflammatory bowel disease: a personality "trait" or a reactive illness?. Hepatogastroenterology 1996, 43(12):1513-1517.
3. Addolorato G., Di Giuda D., De Rossi G., Valenza V., Domenicali M., Caputo F., Gasbarrini A., Capristo E., Gasbarrini G. Regional cerebral hypoperfusion in patients with celiac disease. Am. J. Med. 2004, 116(5):312-317.
4. Antigoni M., Xinias I., Theodouli P., Karatza E., Maria F., Panteliadis C., Spiroglou K. Increased prevalence of silent celiac disease among Greek epileptic children. Pediatr. Neurol. 2007, 36(3):165-169.
5. Batur-Caglayan H.Z., Irkec C., Yildirim-Capraz I., Atalay-Akyurek N., Dumlu S. A case of multiple sclerosis and celiac disease. Case Rep. Neurol. Med. 2013, 576921.
6. Bilgic B., Aygun D., Arslan A.B., Bayram A., Akyuz F., Sencer S., Hanagasi H.A. Silent Neurological Involvement in Biopsy-Defined Coeliac Patients. Neurol Sci. 2013, 34(12):2199-2204.
7. Cascella N.G., Kryszak D., Bhatti B., Gregory P., Kelly D.L., Mc Evoy J.P., Fasano A., Eaton W.W. Prevalence of celiac disease and gluten sensitivity in the United States clinical antipsychotic trials of intervention effectiveness study population. Schizophr. Bull. 2011, 37(1):94-100.
8. Chen S.J., Chao Y.L., Chen C.Y., Chang C.M., Wu E.C., Wu C.S., Yeh H.H., Chen C.H., Tsai H.J. Prevalence of autoimmune diseases in in-patients with schizophrenia: nationwide population-based study. Br. J. Psychiatry 2012, 200(5):374-380.
9. de Magistris L., Familiari V., Pascotto A., Sapone A., Frolli A., Iardino P., Carteni M., De Rosa M., Francavilla R., Riegler G., Militerni R., Bravaccio C. Alterations of the intestinal barrier in patients with autism spectrum disorders and in their first-degree relatives. J. Pediatr. Gastroenterol. Nutr. 2010, 51(4):418-424.
10. Dickerson F., Stallings C., Origoni A., Vaughan C., Khushalani S., Leister F., Yang S., Krivogorsky B., Alaedini A., Yolken R. Markers of gluten sensitivity and celiac disease in recent-onset psychosis and multi-episode schizophrenia. Biol. Psychiatry 2010, 68(1):100-104.
11. Dickerson F., Stallings C., Origoni A., Vaughan C., Khushalani S., Alaedini A., Yolken R. Markers of gluten sensitivity and celiac disease in bipolar disorder. Bipolar Disord. 2012, 13(1):52-58.
12. Dickerson F., Stallings C., Origoni A., Vaughan C., Khushalani S., Yolken R. Markers of gluten sensitivity in acute mania: a longitudinal study. Psychiatry Res. 2012, 196(1):68-71.
13. Dohan F.C., Martin L., Grasberger J.C., Boehme D., Cottrell J.C. Antibodies to wheat gliadin in blood of psychiatric patients: possible role of emotional factors. Biol. Psychiatry 1972, 5(2):127-137.
14. Eaton W., Mortensen P.B., Agerbo E., Byrne M., Mors O., Ewald H. Coeliac disease and schizophrenia: population based case control study with linkage of Danish national registers. BMJ 2004, 328(7437):438-439.
15. Eaton W.W., Byrne M., Ewald H., Mors O., Chen C.Y., Agerbo E., Mortensen P.B. Association of schizophrenia and autoimmune diseases: linkage of Danish national registers. Am. J. Psychiatry 2006, 163(3):521-528.
16. Feldman S., Jackson J.R., Cascella N.G., Eaton W., Fasano A., Warfel D., Santora D., Richardson C.M., Vyas G., Warren K., Carpenter W.T., Kelly D.L. A gluten free diet in people with schizophrenia and anti-tissue transglutaminase or anti-gliadin antibodies. Schizophr. Bull. 2013, 39. (Suppl1).
17. Hadjivassiliou M., Grunewald R., Sharrack B., Sanders D., Lobo A., Williamson C., Woodroofe N., Wood N., Davies-Jones A. Gluten ataxia in perspective: epidemiology, genetic susceptibility and clinical characteristics. Brain 2003, 126(Pt 3):685-691.
18. Hauser W., Janke K.H., Klump B., Gregor M., Hinz A. Anxiety and depression in adult patients with celiac disease on a gluten-free diet. World J. Gastroenterol. 2010, 16(22):2780-2787.
19. Hernandez M.A., Colina G., Ortigosa L. Epilepsy, cerebral calcifications and clinical or subclinical coeliac disease. Course and follow up with gluten-free diet. Seizure 1998, 7(1):49-54.
20. Jackson J., Eaton W., Cascella N., Fasano A., Warfel D., Feldman S., Richardson C., Vyas G., Linthicum J., Santora D., Warren K.R., Carpenter W.T., Kelly D.L. A gluten-free diet in people with schizophrenia and anti-tissue transglutaminase or anti-gliadin antibodies. Schizophr. Res. 2012, 140(1-3):262-263.
21. Jackson J.R., Eaton W.W., Cascella N.G., Fasano A., Kelly D.L. Neurologic and Psychiatric Manifestations of Celiac Disease and Gluten Sensitivity. Psychiatr Q. 2012, 83(1):91-102.
22. Karlsson H., Blomstrom A., Wicks S., Yang S., Yolken R.H., Dalman C. Maternal antibodies to dietary antigens and risk for nonaffective psychosis in offspring. Am. J. Psychiatry 2012, 169(6):625-632.
23. Lau N.M., Green P.H., Taylor A.K., Hellberg D., Ajamian M., Tan C.Z., Kosofsky B.E., Higgins J.J., Rajadhyaksha A.M., Alaedini A. Markers of celiac disease and gluten sensitivity in children with autism. PLoS One 2013, 8(6):e66155.
24. Luostarinen L.K., Collin P.O., Peraaho M.J., Maki M.J., Pirttila T.A. Coeliac disease in patients with cerebellar ataxia of unknown origin. Ann. Med. 2001, 33(6):445-449.
25. Mittelbronn M., Schittenhelm J., Bakos G., de Vos R.A., Wehrmann M., Meyermann R., Burk K. CD8(+)/perforin/granzyme B(+) effector cells infiltrating cerebellum and inferior olives in gluten ataxia. Neuropathology 2010, 30(1):92-96.
26. Okusaga O., Yolken R.H., Langenberg P., Sleemi A., Kelly D.L., Vaswani D., Giegling I., Hartmann A.M., Konte B., Friedl M., Mohyuddin F., Groer M.W., Rujescu D., Postolache T.T. Elevated Gliadin Antibody Levels in Individuals with Schizophrenia. World J Biol Psychiatry 2013, 14(7):509-515.
27. Overall J.E., Gorham D.R. The Brief Psychiatric Rating Scale. Psychol. Rep. 1962, 10(79):812.
28. Overall J.E., Gorham D.R. The Brief Psychiatric Rating Scale (BPRS): recent developments in ascertainment and scaling. Psychopharmacol. Bull. 1988, 24:97-99.
29. Pratesi R., Gandolfi L., Friedman H., Farage L., de Castro C.A., Catassi C. Serum IgA antibodies from patients with coeliac disease react strongly with human brain blood-vessel structures. Scand. J. Gastroenterol. 1998, 33(8):817-821.
30. Randolph C., Tierney M.C., Mohr E., Chase T.N. The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): preliminary clinical validity. J. Clin. Exp. Neuropsychol. 1998, 20(3):310-319.
31. Reichelt K.L., Landmark J. Specific IgA antibody increases in schizophrenia. Biol. Psychiatry 1995, 37(6):410-413.
32. Samaroo D., Dickerson F., Kasarda D.D., Green P.H., Briani C., Yolken R.H., Alaedini A. Novel immune response to gluten in individuals with schizophrenia. Schizophr. Res. 2010, 118(1-3):248-255.
33. Severance E.G., Alaedini A., Yang S., Halling M., Gressitt K.L., Stallings C.R., Origoni A.E., Vaughan C., Khushalani S., Leweke F.M., Dickerson F.B., Yolken R.H. Gastrointestinal inflammation and associated immune activation in schizophrenia. Schizophr. Res. 2012, 138(1):48-53.